Varlitinib modulated gliosis in the early stage of tauopathy in 3-month-old PS19 mice; thus, we investigated the effects of varlitinib on microglial and astrocyte activation in older tau-overexpressing PS19 mice. Here, MAPT is linked to tauopathy.